1. David Adler Research Interests Pharmaceutics Solubility - Phenytoin in IV Solutions Bioavailability/Clinical Equivalence - Sodium Warfarin - RCT Clinical Toxicology - Removal of Drugs by Hemodialysis Instrumentation Point – of – Care - Capillary Whole Blood Prothrombin Time/INR - Warfarin Capillary Whole Blood Activated Partial Thromboplastin Time - Heparin Drug Therapy Management in Chronic Disease – Outcomes of Collaborative Medication Management – RCT Curricular Impact on Student Quality of Life – Survey Access to Care in Underserved Communities – Hepatitis B

2. Core Expertise Clinical Therapeutics -Anticoagulation -Others Clinical Practice Base - Management of Chronic Disease Clinical Population Applications of Point-of-Care Testing

3. Proposed Collaborations with SSPPS Faculty Medication Therapy Management Specialty Care Drug Therapy Management Primary Care Drug Therapy Management Translational Opportunities in Patients with Venous Thromboembolic Disease Select patient populations with: Atrial Fibrillation Deep Venous Thrombosis Mechanical Heart Valves Drug Interactions - Unanswered Questions: Natural Products – e.g. Mango influence on elevating PT/INR Drug-Drug Interactions – MOA and Management of Therapy